The Generic Drug Supply Chain

The Generic Drug Supply Chain

With 89 percent of all prescriptions dispensed in the U.S. last year filled with a generic drug — but those scripts accounting for only 26 percent of total drug costs — generic medicines play a crucial role in the U.S. health care system. To keep lifesaving generics available, it’s important that policymakers understand the supply chain differences between generics and brands. These differences can create different financial incentives for stakeholders throughout the supply chain for branded products and generic products, with the supply chain capturing 64 percent of all revenue on generics, while brand market manufacturers retain 76 percent of revenue.

Read the full factsheet, Introduction to the Generic Drug Supply Chain and Key Considerations for Policymakers.



Your email address will not be published. Required fields are marked *